PodcastThe Directors The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes March 27, 2026Vol.52 No.12By Sara Willa Ernst and Paul Goldberg
Trials & Tribulations Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients March 27, 2026Vol.52 No.12By W. Kimryn Rathmell
Trials & Tribulations In the era of immunotherapy, response rate alone fails to predict true patient benefitRegulators must adapt March 27, 2026Vol.52 No.12By Richard M. Goldberg
Colorectal cancer is now the leading cause of cancer death in patients under 50Why aren’t 45-year-olds getting their recommended CRC screenings? March 27, 2026Vol.52 No.12By Sara Willa Ernst
Cancer Policy FDA issues warning letter to ImmunityBio over misleading claims about cancer drug March 27, 2026Vol.52 No.12By Claire Marie Porter
Cancer Policy FDA withdraws proposed rule that would have banned minors from using tanning beds March 27, 2026Vol.52 No.12By Claire Marie Porter
Cancer Policy FDA issues draft guidance to reduce animal testing March 27, 2026Vol.52 No.12By Claire Marie Porter
Cancer Policy ACA Marketplace enrollees are pinched by steeper healthcare costs, KFF follow-up survey finds March 27, 2026Vol.52 No.12By Sara Willa Ernst
In Brief Roy Herbst named director at Dartmouth Cancer Center March 27, 2026Vol.52 No.12By Paul Goldberg
In Brief Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone March 27, 2026Vol.52 No.12
